Prospects sound for horse gel

APRIL 2010

NATURAL product developer BioProspect has moved one step closer to the production of its horse ulcer treatment paste Giguard, after the successful completion of two major safety studies.

CEO David May, says the trials that took place in Sydney cost $300,000, but he expects approval from the Australian Pesticides and Veterinary Medicines Authority (APVMA) in the next nine months.

Once approved he plans to penetrate the Australian market worth between $2 million and $3 million, which could double if another conifer-based topical gel under development is also approved.

“We are getting Giguard through registration as a natural veterinary health product with a general claim of gastro-intestinal well-being,” he says.

“Part of the strategy of registering with the ATVMA is that you get a free sales certificate, so once registered in Australia we can go to countries like the United Arab Emirates (UAE) where it’s a prerequisite to hold a certificate from the country of origin.

“This opens potential for an export strategy, as we want to sell our product on a global scale.”

The trials started last year, covering a five month period with more than 30 horses, following a smaller case study in Sharjah, UAE in 2008.

Giguard is made from conifer by-products from the Russian forestry industry and is used to treat equine gastric ulcer syndrome (EGUS).

May says eight horses died during the trials, but they were control horses who did not use the product and died of natural causes.

“For instance, one died from a snake bite and another ran into a fence and we had to put it down, but that didn’t affect the trial – they were destined for the knackery anyway,” he says.

Get our daily business news

Sign up to our free email news updates.

 
Whitefox Recruitment founder Luke Hemmings making strides as a careers leader
Partner Content
After relocating his Canberra-founded company Whitefox Recruitment to the Gold Coast la...
Whitefox Recruitment
Advertisement

Related Stories

ASIC secures its first court win for greenwashing against US giant Vanguard

ASIC secures its first court win for greenwashing against US giant Vanguard

The Australian corporate watchdog has caught out one of the world&r...

Medicinal cannabis group Althea shaves $1.5m from its cost base through staff cutbacks

Medicinal cannabis group Althea shaves $1.5m from its cost base through staff cutbacks

Australian-founded medicinal cannabis company Althea Group (ASX: AG...

Charter Hall snares 15pc stake in Hotel Property Investments for $97m from 360 Capital

Charter Hall snares 15pc stake in Hotel Property Investments for $97m from 360 Capital

Listed funds manager 360 Capital Group (ASX: TGP) has offloaded its...

The party’s over: Splendour in the Grass festival cancelled for 2024

The party’s over: Splendour in the Grass festival cancelled for 2024

Splendour in the Grass, Australia’s largest winter music fest...